Poly(ethylene glycol) diacrylate (PEGDA)

Poly(ethylene glycol) diacrylate (PEGDA) is a synthetic, biocompatible polymer widely utilized in the fabrication of hydrogels for tissue engineering and drug delivery (Zhu, 2010, Biomaterials). It is not a therapeutic target in the biological sense, such as a receptor or enzyme, but rather a structural scaffold material (Lin & Anseth, 2009, Pharm Res). PEGDA contains acrylate end-groups that allow it to undergo rapid cross-linking via free-radical polymerization, often initiated by light, to form a stable three-dimensional network (PubChem, CID 16212414). This hydrogel matrix is highly tunable, allowing researchers to adjust mechanical properties to match various human tissues. The term "compatible chemical groups" typically refers to other PEG derivatives like PEG-methacrylate or functional groups like thiols and vinyl sulfones that can be co-polymerized with PEGDA to modify its degradation rate or biological activity (Underhill et al., 2007, Biomaterials). Because PEGDA is biologically inert, it is frequently modified with bioactive ligands like RGD peptides to facilitate cell adhesion (Hoffman, 2002, Adv Drug Deliv Rev). In clinical applications, it serves as a vehicle for the localized and sustained release of drugs, protecting them from degradation while controlling their diffusion into the surrounding environment.

Other names

PEG-diacrylatePolyethylene glycol diacrylatePEG-DAPoly(oxy-1,2-ethanediyl), alpha-(1-oxo-2-propen-1-yl)-omega-((1-oxo-2-propen-1-yl)oxy)-PEGDA monomersAcrylated poly(ethylene glycol)

Acts as a structural scaffold or delivery vehicle; it does not possess a biological mechanism of action as a therapeutic target but provides a physical matrix for cell growth or drug diffusion.